首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Current Treatment Options In Oncology

Current Treatment Options In Oncology杂志,由Springer US出版,于2000年创刊,Bimonthly,出版语言English,ISSN:1527-2729,E-ISSN:1534-6277。

投稿咨询
Current Treatment Options In Oncology
Current Treatment Options In Oncology
Current Treatment Options In Oncology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
5.8
CiteScore
9.3
期刊收录
SCI、SCIE

Current Treatment Options In Oncology(中文译名:《目前肿瘤学的治疗方案》),ISSN:1527-2729,EISSN:1534-6277,是Springer US出版的国际性学术期刊,创刊于2000年,以Bimonthly形式稳定发行,2026年总发文量约82篇。该刊采用非OA开放访问,学科归属为ONCOLOGY。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达5.8,2025年期刊CiteScore为9.3,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类2区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Current Treatment Options In Oncology长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期>12周,或约稿,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAItaly、Japan、Canada、Brazil、France、GERMANY (FED REP GER)等为核心发文国家与地区;UNIVERSITY OF TEXAS SYSTEMMAYO CLINIC、H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE、UNIVERSITY OF CALIFORNIA SYSTEM、MEMORIAL SLOAN KETTERING CANCER CENTER、STATE UNIVERSITY SYSTEM OF FLORIDA、HARVARD UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 67 / 333

80

学科:ONCOLOGY SCIE Q2 158 / 333

52.7

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 77 / 328

76.7

学科:ONCOLOGY SCIE Q3 179 / 328

45.58


中国学者近期发文

1
Imaging Strategies and Research Advances in Gastrointestinal Stromal Tumor

Author:Yang, Dongxiao; Yu, Guanghui

Journal: CURRENT TREATMENT OPTIONS IN ONCOLOGY. 2026; Vol. 27, Issue 1, pp. -. DOI: 10.1007/s11864-026-01389-x

2
Advances in Pharmacologic- and Non-pharmacologic Interventions for Cancer Pain: A Narrative Revie

Author:Wang, Shulin; Yao, Jingyu; Wang, Qiuli; Yang, Wei; Zhao, Jun

Journal: CURRENT TREATMENT OPTIONS IN ONCOLOGY. 2026; Vol. 27, Issue 1, pp. -. DOI: 10.1007/s11864-026-01393-1

3
Advanced Mucosal Melanoma Therapies: Current Status and Future Direction

Author:Zhang, Yiqun; Zhao, Dawei; Wu, Di

Journal: CURRENT TREATMENT OPTIONS IN ONCOLOGY. 2026; Vol. 27, Issue 1, pp. -. DOI: 10.1007/s11864-025-01372-y

4
Review on Photodynamic Therapy Combined with T-Cell Immunotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Mechanisms, Challenges, and Future Direction

Author:Wang, Wei; Liu, Ping; Lin, Haonan

Journal: CURRENT TREATMENT OPTIONS IN ONCOLOGY. 2026; Vol. 27, Issue 1, pp. -. DOI: 10.1007/s11864-026-01388-y

5
Whole Lung Irradiation in Ewing Sarcoma with Pulmonary Metastases: Critical Appraisal of Evolution, Evidence, and Future Pathways in Precision Oncolog

Author:Yang, Yuanyou; Xie, Lu; Xu, Jie; Sun, Xin; Ren, Gang

Journal: CURRENT TREATMENT OPTIONS IN ONCOLOGY. 2026; Vol. 27, Issue 1, pp. -. DOI: 10.1007/s11864-026-01387-z

6
Transforming a Roadblock into a Roadmap: Evolving HFSR Management From Adverse Event to Efficacy Biomarke

Author:Xu, Qian; Chen, Jinhan; Sun, Huiwen; Liu, Xingyu; Zhao, Fangmin; Shu, Qijin

Journal: CURRENT TREATMENT OPTIONS IN ONCOLOGY. 2026; Vol. 27, Issue 1, pp. -. DOI: 10.1007/s11864-026-01385-1

7
Whole Abdominal Radiotherapy in Bone and Soft Tissue Sarcomas: Indications, Techniques, Clinical Outcomes, and Future Direction

Author:Yang, YuanYou; Xie, Lu; Sun, Xin; Xu, Jie; Ren, Gang

Journal: CURRENT TREATMENT OPTIONS IN ONCOLOGY. 2026; Vol. 27, Issue 1, pp. -. DOI: 10.1007/s11864-026-01384-2

8
Advances in Systemic Therapy for Metastatic Pancreatic Neuroendocrine Neoplasm

Author:Yi, Minxiao; Shen, Qian

Journal: CURRENT TREATMENT OPTIONS IN ONCOLOGY. 2026; Vol. 27, Issue 1, pp. -. DOI: 10.1007/s11864-026-01382-4

9
Acupuncture and Acupressure for Cancer Symptom Management: an Opinion Statement Based on Preliminary Evidence Mappin

Author:Lukkahatai, Nada; Zhang, Jingyu; Benjasirisan, Chitchanok; Phongphanngam, Sutthida; Shen, Aomei; Jaiman, Phakjira; Kawi, Jennifer; Smith, Thomas J.; Saligan, Leorey N

Journal: CURRENT TREATMENT OPTIONS IN ONCOLOGY. 2026; Vol. 27, Issue 1, pp. -. DOI: 10.1007/s11864-025-01369-7

10
Advances in Personalized Treatment and Prognostic Factors of Follicular Lymphom

Author:Cheng, Shijia; Liu, Yanyan

Journal: CURRENT TREATMENT OPTIONS IN ONCOLOGY. 2025; Vol. 26, Issue 4, pp. 313-330. DOI: 10.1007/s11864-025-01297-6


在线咨询

Current Treatment Options In Oncology

国际简称:CURR TREAT OPTION ON参考译名:目前肿瘤学的治疗方案

年发文量:82 CiteScore:9.3 是否预警:否 Gold OA文章占比:32.45% 研究类文章占比:0.00%

杂志社联系方式:SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Current Treatment Options In Oncology